~~<i id='F6301F33A6'><strike id='F6301F33A6'><tt id='F6301F33A6'><pre id='F6301F33A6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：Wikipedia 2025-09-27 21:27:00 - browse：4

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease.

If things go well, Roche could pay Alnylam up to $2.8 billion in total.

Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug firms have struggled to one-up existing treatments for high blood pressure and high cholesterol that are now available as cheap generics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Ford recalls 870K F

leisure time

Wikipedia

hotspot

leisure time

focus

AdobeEveryoneknowsthattheUnitedStatesistheonlyhigh-incomecountrywithoutuniversalhealthinsurance.Acco

WSS

Public health communication lessons from Covid

Marc Tessier

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

As the dark side of IVF slowly comes into focus, even more transparency is needed

Hospitals, health systems can help patients avoid medical debt

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

hotspot

Wikipedia

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Brain MRIs reveal impact of 'toxic stress' on Black children

BioMarin wins approval for gene therapy to treat hemophilia A

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Affirmative action in medical school literally saved lives

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Is it ever OK for doctors to lie to their patients?

Moonlake's readout produced a cash windfall. Risks remain

Will biotech layoffs continue through 2023?

Wikipedia

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Crowdfunding for medical bills sidesteps core problem, author says

Class action alleges UnitedHealth concealed DOJ probe

Stoke drug shows lower activity against childhood epilepsy

Brain technologies pose threats that are all too real, experts warn

Interest rates are at a 22

hotspot

hotspot

leisure time

focus